A   B   C   D   E   F   H   I   J   K   L   M   N   O   P   Q   R   S   T   V  

radiation

Paper Title Other Keywords Page
II-02 The Operation of Cyclotrons Used for Radiopharmaceutical Production cyclotron, target, controls, isotope-production 115
 
  • T. Grey-Morgan
    Cyclotron Isotopes Manufacturing, Buckinghamshire, England
  • R.E. Hubbard
    Medi + Physics Inc., Arlington Heights, Illinois, USA
  
IV-01 Material Research with Beams at Cyclotron Energies (Invited Paper) ion, cyclotron, proton, heavy-ion 149
 
  • K. Ziegler
    HMI, Berlin, Germany
  
IV-03 The Use of Heavy Ion Cyclotrons of the Flerov Laboratory of Nuclear Reactions in Condensed Matter Investigations ion, heavy-ion, neutron, electron 162
 
  • R.Ts. Oganessian, A.Yu. Didyk
    JINR, Dubna, Russia
  
IV-05 Radionuclide Technique in Mechanical Engineering (RTM) injection, ion, cyclotron, diagnostics 171
 
  • P. Fehsenfeld, A. Kleinrahm
    FZK, Karlsruhe, Germany
  • V. Novikov
    Kurchatov Institute, Moscow, Russia
  
IV-09 A Simple Method for Estimating Activation Sensitivities of Different Elements / Isotopes with Cyclotron Produced Neutrons neutron, target, cyclotron, BNL 187
 
  • M.A. Chaudhri
    Austin Hospital & University of Melbourne, Melbourne, Australia
  
IV-11 External High Current Targetry for Radioisotope Production target, TRIUMF, cyclotron, vacuum 196
 
  • N.R. Stevenson, W.Z. Gelbart
    TRIUMF, Vancouver, Canada
  
IV-12 A Remotely Controlled Robotic Vehicle for Work Within Radioactive Environments target, controls, cyclotron, TRIUMF 198
 
  • N.R. Stevenson, P. Bloemhard, M. Brigham, J. Ko, C. LaForge, J. Orzechowski, E. Pattyn, T. Rattray
    TRIUMF, Vancouver, Canada
  
V-01 The New Molecular Medicine accumulation, site, ion, monitoring 202
 
  • H.N. Wagner, Jr.
    The Johns Hopkins University, Baltimore, Maryland, USA
  
VI-01 Accelerators for Charged Particle Therapy: Performance Criteria from the User Point of View (Invited Paper) proton, ion, photon, target 226
 
  • E. Pedroni
    PSI, Villigen, Switzerland
  
VI-02 Current and Potential Clinical Indications of Proton Irradiation (Invited Paper) proton, photon, controls, site 234
 
  • A.F. Thornton, H.D. Suit
    Harvard Medical School, Boston, Massachusetts, USA
  
VI-03 Pion Therapy for Cancer - What are the Prospects? photon, TRIUMF, controls, background 242
 
  • G.B. Goodman
    University of British Columbia, Vancouver, Canada
  
VI-06 Health Physics Data Acquisition System at the National Medical Cyclotron cyclotron, monitoring, target, neutron 252
 
  • B.N. Mukherjee
    ANSTO, Menai, NSW, Australia
  • D.W. Arnott
    National Medical Cyclotron, Camperdown, NSW, Australia
  
VI-08 A Proton Therapy Facility Plan proton, cyclotron, synchrotron, electron 258
 
  • S. Fukumoto, Y. Hayakawa, T. Inada, A. Maruhashi, M. Sato, J. Tada, Y. Takada, H. Tsuji, H. Tsujii
    University of Tsukuba, Ibaraki, Japan
  • K. Endo, Y. Irie, K. Muto
    KEK, Ibaraki, Japan
  
VI-09 Continued Operation of the Seattle Clinical Cyclotron Facility neutron, cyclotron, controls, target 262
 
  • R. Risler, S. Brossard, J. Jacky, I. Kalet, P. Wootton, F. Ziai
    University of Washington, Seattle, Washington, USA
  
XC-05 The AGOR Superconducting Extraction Channel EMC2 cyclotron, AGOR, background, extraction 585
 
  • K. Pieterman, J.A.M. Dam
    Cryocon B.V., Amersfoort, The Netherlands
  • H.J.H. ten Kate
    TU Twente, Enschede, The Netherlands
  • S. Gustafsson
    IPN, Orsay, France
  
XI-14 Formal Specifications for a Cyclotron Control System controls, cyclotron, neutron, status 689
 
  • J. Jacky, R. Risler
    University of Washington, Seattle, Washington, USA